Pacheco-Serran Helson MD is categorized under Doctors in El Paso, TX and active since 2008.
Pacheco-Serran Helson MD was established in 2008, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Helson Pacheco-Serran at the company’s single location by writing to 1700 North Oregon St # 660, El Paso, Texas TX 79902 or by phoning (915) 521-1180. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Pacheco-Serran Helson MD |
Contact Person: | Helson Pacheco-Serran |
Address: | 1700 North Oregon St # 660, El Paso, Texas 79902 |
Phone Number: | (915) 521-1180 |
Website Address: | neurosurgicalspecialistsofelpaso.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 2008 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Doctors |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Pacheco-Serran Helson MD was started in 2008 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Helson Pacheco-Serran for inquiries that concern Pacheco-Serran Helson MD by calling the company number (915) 521-1180, as your correspondence is most welcome. Additionally, the physical location of the single location of Pacheco-Serran Helson MD can be found at the coordinates 31.769223,-106.49756 as well as the street address 1700 North Oregon St # 660 in El Paso, Texas 79902.
For its online presence, you may visit Pacheco-Serran Helson MD’s website at neurosurgicalspecialistsofelpaso.com and engage with its social media outlets through on Twitter and on Facebook.